Posts filed under ‘target date’

Intermune Inc ( Itmn ) $45.44 -5.41% Whatstrading.Com: Objective …

Intermune ( ITMN ) is halted, news pending. It’s probably related to Esbriet(R) (pirfenidone) for pulmonary fibrosis, which an FDA panel recommended approval of on Mar 9. A May 4 target date has been set under the PDUFA. …
Read More…

May 5, 2010 at 4:22 pm Leave a comment


Calendar

September 2017
M T W T F S S
« Aug    
 123
45678910
11121314151617
18192021222324
252627282930  

Posts by Month

Posts by Category